Scribe Therapeutics 8.58M share IPO priced at $15.00
The deal guidance is...
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
The deal guidance is...
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.